AP2A2

AP2A2 encodes the alpha-2 subunit of the AP-2 adaptor complex and functions as a core component of clathrin-mediated endocytosis, selecting cargo for internalization at the plasma membrane through its appendage domain (PMID:38772452). In adipocytes it drives β-adrenergic receptor internalization: loss of Ap2a2 retains β2- and β3-adrenergic receptors at the cell surface and impairs cAMP/PKA-driven lipolysis, placing it downstream of PPARα as a transcriptional target in adipose tissue (PMID:31533003). Its endocytic function depends on recognition of PEST-like sorting determinants, exploited by the Listeria pore-forming toxin LLO, whose PEST-like sequence binds AP2A2 to drive its endocytic removal from the plasma membrane and limit cytotoxicity; this requirement is interchangeable with a heterologous GPCR PEST sequence (PMID:29902442). The complete AP-2 complex (Ap2a2, Ap2m1, Ap2s1) is also required for post-phagosomal cytosolic replication of intracellular Listeria (PMID:40847839). A homozygous missense variant in AP2A2 causes hereditary spastic paraplegia with corpus callosum thinning, acting through reduced protein levels and defective transferrin receptor endocytosis in patient iPSC-derived neurons, with the mutant α-appendage domain showing impaired binding to accessory endocytic proteins (PMID:38772452). In the brain AP2A2 localizes to microglia and accumulates in the detergent-insoluble fraction of cognitively impaired brains, and its knockdown reverses Alzheimer-associated microglial proteomic phenotypes (PMID:34820873, PMID:41388808). AP2A2 additionally undergoes asymmetric segregation during hematopoietic stem cell cytokinesis and acts as a positive regulator of HSC activity (PMID:22174158).

1. 2011 Medium

   Established AP2A2 as more than a housekeeping endocytic subunit by showing it is a fate-influencing factor that asymmetrically segregates during stem cell division.

   Evidence In vitro-to-in vivo HSC functional screen with live-cell videomicroscopy of cytokinesis

   PMID:22174158

   Open questions at the time

   • Mechanism linking asymmetric AP2A2 segregation to fate determination not resolved
   • No connection drawn to its endocytic role
   • No molecular partners identified in this context
2. 2018 High

   Defined the cargo-recognition logic of AP2A2 by showing it binds PEST-like sorting sequences, here used by the Listeria toxin LLO to be cleared from the plasma membrane.

   Evidence Co-IP, Ap2a2 knockdown with cytotoxicity readout, and functional complementation with a heterologous GPCR PEST sequence

   PMID:29902442

   Open questions at the time

   • Structural basis of PEST recognition by the appendage domain not defined
   • Endogenous mammalian PEST-bearing cargo not enumerated
3. 2019 High

   Demonstrated a physiological cargo and pathway by showing AP2A2 internalizes β-adrenergic receptors to sustain lipolytic signaling, and placed it transcriptionally downstream of PPARα.

   Evidence Adipocyte-specific Ap2a2 knockout mice with cAMP/PKA, lipolysis, and surface receptor assays plus PPARα agonist phenotyping

   PMID:31533003

   Open questions at the time

   • Direct AP2A2–β-AR contact not structurally mapped
   • Whether PPARα regulation is direct (promoter binding) not shown
4. 2021 Medium

   Distinguished AP2A2 from its paralog AP2A1 in the diseased brain, localizing AP2A2 to microglia and to the detergent-insoluble fraction of cognitively impaired tissue.

   Evidence Isoform-specific validated antibodies, immunohistochemistry/immunofluorescence with colocalization, and detergent-solubility fractionation of human brain

   PMID:34820873

   Open questions at the time

   • Functional consequence of microglial localization not tested
   • Cause of detergent-insolubility (aggregation vs. complex assembly) unknown
5. 2024 High

   Causally linked AP2A2 loss-of-function to human neurological disease, tying a missense variant to defective neuronal endocytosis via impaired appendage-domain binding.

   Evidence Whole exome sequencing, patient iPSC-derived neuron Western blot and transferrin receptor endocytosis assay, mutant appendage-domain IP, and Xenopus ap2a2 knockout

   PMID:38772452

   Open questions at the time

   • Specific accessory proteins lost from mutant appendage not all identified
   • Cell type driving the spastic paraplegia phenotype not pinpointed
6. 2025 Medium

   Showed the intact AP-2 complex is co-opted for intracellular Listeria replication at a post-phagosomal cytosolic step, distinct from earlier toxin-clearance role.

   Evidence Proteomics and CRISPR/Cas9 knockout of Ap2a2/Ap2m1/Ap2s1 with intracellular proliferation assays across macrophage, dendritic, and epithelial lines

   PMID:40847839

   Open questions at the time

   • Molecular target of AP-2 during cytosolic replication unknown
   • Reconciliation with the protective LLO-clearance role not addressed
   • Single-lab study
7. 2025 Medium

   Functionally validated AP2A2 as an Alzheimer's disease microglial target by showing its knockdown reverses AD-associated proteomic signatures.

   Evidence siRNA knockdown with cellular phenotype and quantitative proteomics in Psen2-knockdown BV2 microglia

   PMID:41388808

   Open questions at the time

   • Mechanistic link between AP2A2 and AD proteomic changes not defined
   • In vivo validation absent
   • Single-lab study

• How a single endocytic adaptor subunit reconciles its roles across receptor internalization, toxin clearance, pathogen exploitation, stem cell fate, and neurodegeneration remains unresolved.
• No structural model of AP2A2 cargo/accessory-protein recognition in the timeline
• Tissue-specific cargo repertoire incompletely mapped
• Mechanism connecting microglial AP2A2 to AD pathology unknown